Diomed Holdings, Inc. to Present at C.E. Unterberg, Towbin Life Sciences Conference

  
    
  
  
    
      Diomed Holdings, Inc. (AMEX:DIO), a leading developer and marketer of 
      minimally-invasive medical technologies, including its patented 
      EndoVenous Laser Treatment (EVLT®) for 
      varicose veins, today announced that James Wylie, President and CEO, 
      will be presenting an overview of the Company’s 
      business at the upcoming C. E. Unterberg, Towbin Life Sciences Conference 
      at the Palace Hotel in New York on Tuesday, October 31, 2006 at 1:00 
      p.m. EST.
    
    
      To take part in this webcast presentation, please login at either http://ir.diomedinc.com 
      or http://www.wsw.com/webcast/ceut5/dio/.
    
    
      About Diomed
    
    
      Diomed develops and commercializes minimal and micro-invasive medical 
      procedures that use its proprietary laser technologies and disposable 
      products. Diomed’s EVLT® 
      laser vein ablation procedure is used in varicose vein treatments. 
      Diomed also provides photodynamic therapy (PDT) for use in cancer 
      treatments, and dental and general surgical applications. The EVLT® 
      procedure and the Company’s related products 
      were cleared by the United States FDA in January of 2002. Along with 
      lasers and single-use procedure kits for its EVLT® 
      laser vein treatment, the Company provides its customers with state of 
      the art physician training and practice development support. Additional 
      information is available on the Company’s 
      website: www.evlt.com.
    
    
      EVLT® is a registered trademark of Diomed 
      Inc., Andover, MA.
    
  
Diomed Holdings, Inc. (AMEX:DIO), a leading developer and marketer
of minimally-invasive medical technologies, including its patented
EndoVenous Laser Treatment (EVLT(R)) for varicose veins, today
announced that James Wylie, President and CEO, will be presenting an
overview of the Company's business at the upcoming C. E. Unterberg,
Towbin Life Sciences Conference at the Palace Hotel in New York on
Tuesday, October 31, 2006 at 1:00 p.m. EST.

   To take part in this webcast presentation, please login at either
http://ir.diomedinc.com or http://www.wsw.com/webcast/ceut5/dio/.

   About Diomed

   Diomed develops and commercializes minimal and micro-invasive
medical procedures that use its proprietary laser technologies and
disposable products. Diomed's EVLT(R) laser vein ablation procedure is
used in varicose vein treatments. Diomed also provides photodynamic
therapy (PDT) for use in cancer treatments, and dental and general
surgical applications. The EVLT(R) procedure and the Company's related
products were cleared by the United States FDA in January of 2002.
Along with lasers and single-use procedure kits for its EVLT(R) laser
vein treatment, the Company provides its customers with state of the
art physician training and practice development support. Additional
information is available on the Company's website: www.evlt.com.

   EVLT(R) is a registered trademark of Diomed Inc., Andover, MA.